Basic Poxet Information

• INN (International Nonproprietary Name): Dapoxetine.
• Brand Names Available In United Kingdom: Not specified.
• ATC Code: G04BX14.
• Forms & Dosages: Oral tablet; 30 mg and 60 mg; commonly packed in blisters of 1, 3, 6 or 10 tablets.
• Manufacturers In United Kingdom: Not specified.
• Registration Status In United Kingdom: Not specified.
• OTC / Rx Classification: Prescription Only (Rx).

Key Findings From Recent Trials

Major 2022–2025 Studies

Patients and prescribers want clear evidence that a short‑acting SSRI works when taken as needed.

Randomised controlled trials from 2022 to 2024 compared dapoxetine with placebo in men diagnosed with lifelong premature ejaculation.

Pooled analyses and high‑quality RCTs consistently assessed intravaginal ejaculatory latency time, patient‑reported control and partner satisfaction.

Real‑world observational studies from 2022–2024 complemented RCTs by showing similar benefit but higher discontinuation because of tolerability in routine care.

Main Outcomes

Trials reported clinically meaningful increases in IELT compared with placebo, often expressed as median multiples of baseline.

Patient‑reported outcome measures such as PEDT and satisfaction scales showed improved control and sexual satisfaction with dapoxetine.

The largest effects appeared in men with lifelong premature ejaculation and shorter baseline IELT.

Evidence supports starting at 30 mg and escalating to 60 mg when efficacy is insufficient and tolerability allows.

Safety Observations

Common adverse events across trials were transient and included nausea, dizziness, headache and insomnia.

Syncope and serotonin syndrome were rare but have been reported when interacting drugs were present.

Elderly patients and those with cardiac disease showed higher risk of adverse events in pooled safety analyses.

These safety signals align with product labelling and cautionary prescribing rules for dapoxetine.

Clinical Mechanism Of Action

Layman’s Explanation

Men often ask how a tablet taken before sex can delay ejaculation.

Dapoxetine is a short‑acting SSRI that is taken 1–3 hours before intercourse to boost brain signals that slow the ejaculatory reflex.

The effect is temporary, so men avoid long‑term SSRI exposure and its chronic sexual side effects.

Scientific Breakdown

Dapoxetine blocks the serotonin transporter (SERT) in synapses, increasing synaptic 5‑HT levels.

Raised serotonin influences multiple 5‑HT receptor subtypes, with interplay at 5‑HT1A, 5‑HT1B and 5‑HT2C receptors implicated in slowing ejaculatory pathways.

Enhanced serotonergic tone modulates both spinal and supraspinal circuits that control ejaculation, producing longer IELT and improved perceived control.

Pharmacokinetics (On‑Demand Profile)

Dapoxetine is rapidly absorbed with a Tmax of around one hour after oral dosing.

The formulation provides substantial oral bioavailability that supports single‑dose on‑demand use 1–3 hours before sexual activity.

Clearance is hepatic and involves CYP enzymes, so strong CYP3A4 inhibitors can raise exposure and increase adverse events.

Receptor Pharmacology & Downstream Effect

The short elimination half‑life differentiates dapoxetine from daily SSRIs and reduces risk of persistent sexual dysfunction.

Nevertheless, acute CNS effects such as dizziness and, rarely, syncope can occur because of serotonergic action and central nervous system penetration.

Contraindications with MAOIs and strong CYP inhibitors reflect these receptor and pharmacokinetic interactions.

Scope Of Approved And Off‑Label Use

United Kingdom Approvals

Where dapoxetine is authorised, it is indicated for the treatment of premature ejaculation in men.

Priligy is the established branded dapoxetine available in many European and Asian markets, while Poxet is an Indian generic commonly seen on international e‑pharmacies.

UK‑specific registration for Poxet is not specified in the available product data.

Clinicians and patients should check MHRA and local formularies for current licensing and supply pathways before prescribing or recommending importation.

Notable Off‑Label Trends

Off‑label practices occasionally include using daily SSRIs for chronic management and combining dapoxetine with a PDE5 inhibitor where erectile dysfunction coexists.

Combination products such as tadalafil plus dapoxetine appear in some markets for men with both conditions, but such mixes raise regulatory and safety complexity.

Daily dapoxetine dosing is discouraged and not supported by standard product guidance.

Dosage Strategy

General Dosing

Start with 30 mg taken 1–3 hours before sexual activity.

If response is inadequate and the 30 mg dose is well tolerated, increase to 60 mg once only, maintaining a maximum of one tablet per 24 hours.

Do not take dapoxetine every day; it is intended as required prior to intercourse.

Condition‑Specific Dosing

Men with lifelong premature ejaculation follow the same starting strategy of 30 mg and potential escalation to 60 mg.

In acquired premature ejaculation, treat reversible causes first — for example, erectile dysfunction, prostatitis or psychiatric contributors — and consider on‑demand dapoxetine as part of a broader plan.

Use caution in older men over 65 and avoid dapoxetine in moderate or severe hepatic impairment.

Titration And Practical Tips

Try several sexual attempts at 30 mg (for example, 4–8 uses) to judge efficacy and tolerability before increasing to 60 mg.

A light snack with the tablet may reduce nausea for some men, but advise avoidance of excess alcohol in the dosing window.

Avoid concomitant strong CYP3A4 inhibitors and serotonergic medicines where possible to reduce risk of interactions.

Safety Protocols

Contraindications

Absolute contraindications include known hypersensitivity to dapoxetine and concurrent or recent MAOI therapy within 14 days.

Significant cardiac disease such as heart failure or arrhythmias, moderate to severe hepatic impairment and a history of syncope, mania or severe depression are also contraindications.

These contraindications reflect the safety data and product labelling for dapoxetine.

Adverse Effects

The most commonly reported adverse effects are nausea, dizziness, headache, diarrhoea, insomnia, fatigue, anxiety and flushing.

Discontinuation in routine care is often driven by nausea and dizziness rather than inefficacy.

Rare but serious risks include syncope and serotoninergic toxicity when combined with other serotonergic drugs.

Monitoring & Risk Mitigation

Perform a pre‑treatment review of cardiac history, current medications (notably MAOIs and strong CYP3A4 inhibitors), hepatic and renal function and fainting history.

Document informed consent where patients are accessing imported or unlicensed products and advise immediate medical review for fainting, severe agitation, tremor or seizures.

Report serious adverse events to the MHRA Yellow Card scheme when dapoxetine is used in the United Kingdom.

Interaction Mapping

Food Interactions

There is no strict food restriction, but heavy alcohol intake around dosing increases the risk of dizziness and syncope.

Advise patients to avoid excess drinking in the hours surrounding dose administration.

Drug Combinations To Avoid

Do not co‑prescribe dapoxetine with MAOIs or within 14 days of MAOI cessation.

Exercise caution with other serotonergic agents such as SSRIs, SNRIs or triptans due to the risk of serotonin syndrome.

Avoid strong CYP3A4 inhibitors which raise dapoxetine exposure and the likelihood of adverse effects.

CYP Interactions & Clinical Impact

Dapoxetine is metabolised via hepatic CYP pathways, notably CYP3A4, so interacting drugs such as ketoconazole or ritonavir can elevate plasma levels.

Elevated exposure can increase CNS adverse effects and raise safety concerns in patients with cardiac comorbidity.

Careful medication reconciliation and, where appropriate, alternative treatments are necessary when interacting medicines cannot be stopped.

Patient Experience Analysis

Survey Data

Patient‑reported outcome measures in trials and surveys show improved perceived ejaculatory control and satisfaction with dapoxetine use.

Validated instruments such as PEDT often record improvements after on‑demand dapoxetine compared with placebo.

However, real‑world adherence is variable and commonly limited by side effects and modest benefit in some individuals.

Forum Trends

Online discussion shows praise for rapid onset and the convenience of on‑demand dosing, with concerns mainly about nausea and dizziness.

Patients frequently ask about access in the UK and report using private clinics or importation channels where local availability is restricted.

Some men report benefit from combining a PDE5 inhibitor with dapoxetine when erectile dysfunction is also present, but combination use requires careful oversight.

Adherence And Discontinuation Reasons

The primary reasons for stopping dapoxetine are adverse effects, perceived insufficient benefit and access or cost issues when importing generics such as Poxet.

Counselling on dose timing, nausea mitigation strategies and realistic expectations can improve persistence for men who benefit.

Distribution And Pricing Landscape

Manufacturers & Supply Chains

Poxet is manufactured by Sunrise Remedies Pvt Ltd in India and is commonly supplied via international e‑pharmacies and parallel importers.

Priligy, manufactured by Menarini, is the branded dapoxetine product in many European and Asian markets.

Multiple generic suppliers from India, Southeast Asia and Eastern Europe provide blister packs of 30 mg and 60 mg tablets.

Pricing And Online Markets

Generic dapoxetine products such as Poxet typically cost less than branded Priligy, with prices varying widely between online vendors.

Blister counts range from single tablets up to packs of ten, and authenticity checks are essential because counterfeit or substandard products have been reported.

Buyers should verify pharmacy credentials and insist on a prescription where required by law.

Importation And Legal Considerations (United Kingdom)

Dapoxetine is prescription‑only where approved and importing unlicensed medicines carries regulatory and safety risks.

UK patients often access dapoxetine through private clinic prescriptions, personal importation rules or authorised branded product supply where available.

Always check MHRA guidance and use verified pharmacies to ensure supply chain traceability and pharmacovigilance reporting.

In our online pharmacy, poxet is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Alternative Options

Comparison Table (Key Measures)

• Dapoxetine (Poxet/Priligy): On‑demand; rapid onset; 30→60 mg; pros include short action and lower risk of chronic sexual dysfunction; cons include acute nausea and dizziness and prescription status.
• Daily SSRIs (sertraline, paroxetine, fluoxetine): Off‑label for PE; pros include extensive evidence base; cons include daily dosing and chronic sexual side effects.
• Topical Anaesthetics (lidocaine/prilocaine): Low systemic adverse effects; pros include minimal systemic exposure; cons include partner transfer and reduced sensation.
• Behavioural Therapies (stop‑start, squeeze): Non‑pharmacological; pros include durable skills and no drug side effects; cons include time commitment and variable adherence.

Pros And Cons

Choose treatment based on PE subtype, comorbid erectile dysfunction, patient preference and tolerance for side effects.

Dapoxetine is particularly suitable for men who want an on‑demand option and to avoid continuous SSRI exposure.

Daily SSRIs remain an alternative when long‑term serotonergic modulation is acceptable and monitored.

Regulatory Status

Global Approvals Summary

Dapoxetine is authorised in multiple jurisdictions for premature ejaculation under brands such as Priligy and various generics including Poxet in India.

The ATC classification for dapoxetine is G04BX14.

Dapoxetine is not approved by the US FDA as of 2024.

UK Regulatory Considerations

Post‑Brexit licensing and supply routes affect availability in the United Kingdom and clinicians should consult MHRA resources prior to prescribing or advising importation.

Prescription‑only status applies in markets where dapoxetine is authorised, and pharmacovigilance reporting to the Yellow Card scheme is essential for any adverse events observed in UK patients.

Consolidated FAQ

Common Patient Questions

Can I take Poxet in the United Kingdom?

Availability varies and dapoxetine is prescription only in countries where it is authorised, so check with a prescriber or MHRA guidance before sourcing medication.

How long before sex should I take it?

Take dapoxetine 1–3 hours before sexual activity.

Can I drink alcohol when I take it?

Avoid excess alcohol around dosing as it increases the risk of dizziness and fainting.

What if I miss a dose?

Skip the missed dose and take the tablet only when needed; do not double up.

Can I take it daily?

No; dapoxetine is indicated for on‑demand use rather than daily administration.

Clinician Quick‑Checks

Screen for cardiac disease, MAOI use, moderate to severe hepatic impairment, concomitant serotonergic drugs and CYP3A4 inhibitors before prescribing.

Start at 30 mg and reassess after several uses to determine whether escalation to 60 mg is appropriate.

Report serious adverse events to the MHRA Yellow Card scheme.

Visual Guide

What The Packaging Looks Like (Notes)

Poxet commonly appears as blister packs marked Poxet-30 or Poxet-60 and may contain local language labelling depending on the supplier.

Priligy is typically presented in EU‑style blister packs with Menarini labelling in markets where it is authorised.

Packaging authenticity should be checked and patients should be encouraged to bring packs to consultations for verification.

Patient Counselling Visuals To Provide

Create a single‑page handout covering dosing timeline (take 1–3 hours prior), one‑dose‑per‑24‑hour rule, contraindications checklist and common side effects and actions.

Include a reminder to keep blister packs and batch numbers for pharmacovigilance and to verify pharmacy registration when sourcing online.

Storage And Transport

Practical Guidance For Pharmacies And Patients

Store dapoxetine tablets below 30°C in a dry place away from direct sunlight and humidity.

Keep tablets in original blister packaging until use and follow standard UK pharmacy storage practices.

Advise patients not to store medication in bathrooms or other humid environments.

Cold Chain And Stability Notes

No cold chain is required for standard dapoxetine tablets and room temperature storage is acceptable.

Respect printed expiry dates and advise disposal of surplus or expired tablets in accordance with local NHS or pharmacy guidance.

Guidelines For Proper Use

Prescriber Checklist

Confirm diagnosis of premature ejaculation and document baseline IELT or validated PROMs where possible.

Review cardiac history, hepatic and renal function, concomitant medications including MAOIs, serotonergic drugs and CYP3A4 inhibitors.

Exercise caution for patients over 65 and discuss the licensed status and any importation considerations.

Patient Counselling Script

Explain clearly that dapoxetine is taken 1–3 hours before sexual activity and that treatment starts at 30 mg.

Ask the patient to try several attempts at 30 mg and to report nausea, dizziness or any fainting before increasing dose.

Advise avoidance of alcohol excess and not to combine with MAOIs or other serotonergic medicines.

Follow‑Up And Escalation

Review efficacy and adverse effects after 4–8 uses of 30 mg and consider escalation to 60 mg only if tolerated and needed.

If adverse effects are concerning or interactions suspected, stop dapoxetine and reassess treatment options such as topical anaesthetics, behavioural therapy or off‑label SSRIs.

Refer for cardiology opinion if cardiac concerns arise during assessment or follow‑up.

Delivery Across United Kingdom

Closing Notes For Clinicians And Patients

Poxet (dapoxetine) provides an evidence‑based, on‑demand option for men with premature ejaculation when used according to product guidance.

Start treatment at 30 mg and consider 60 mg only after assessing tolerance and benefit.

Screen carefully for contraindications and drug interactions, particularly with MAOIs and strong CYP3A4 inhibitors.

Advise patients about common side effects and the importance of reporting fainting or severe serotoninergic symptoms promptly.

When sourcing Poxet or Priligy, use verified pharmacies and adhere to UK regulatory guidance and Yellow Card reporting for adverse events.